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Infarct size (% of LV mass at 8 weeks) wes similar between AGEI + 
and ACE (14 ± 3% nnd t6 ~ 4%), ~HR we5 greater in ACEI + p (-35 ± 18 
versus -17 ~ 19, p = 0,06), but ,~BP was similar. 
,~LVMI AEDVI ~,~VI ,~EF 
ACEI + p +0,,'t ~l~ 03 +0,0 ;L 0,5 +0,1 .t~ 0,2' ,-10 ~ 10' 
ACEI +0,0 '~: 0,3 +09 ~; 0,5 .~0,1 I 0,1 ~22 • 4 
'p., 0,05 versus ACEI 
The fail In %S in adJ (8 ± 3% in ACEI +/I and 10 ± 3% In AGEI) was 
slmllar, In ~d~ and rum, BF and BF restore were similar, The retie of I~MIBG 
qptak6 in ~di#em was higher in ACEI +/I (0,93 .t~ 0,0O verau~ 0,80 ~ 0,07, 
p .~ 0,04), 
Thus, I t blockade, when added to ACE inhibition after MI, does not ~lter 
LV 511~, regional function or blood flow, but improve5 aJe~ticn fra(=tion and 
adja(~ant regional ~ympathQflc Innerv~tlon, 
~ Eftecte of Amlodlplne Enalaprll and on Left 
Vantrlcul~r Hypertrophy and Functlon During 
Hullng After Late Raparfuelon of Anterior 
Myocardial Inta~tlon In Dogs 
B,I, Jug~utt, UnNemtfy of Att~rfn. Edmonton, Altmrfn, C~n~d~ 
f~¢kground; The effects of the calcium channel blocker amlodiplna (AML) 
and the anglolensln-convertlng enema inhibitor aoalapril (EL) on left ventnc- 
ular (LV) hyporlrophy and function during healing after roperfusod myocardial 
infarction (MI) have not bean compared, 
Mefhod~: Remodeling and function (echoc~rdlegrams) and hemedynam- 
t,~ were measured serially in dogs mndomlzod 24 h following repodusion 
(RP), made 2 h after antarlor MI, to oral AML (5 mg BID), EL (5 mg BID) or 
controls (no drug er no RP) for 6 weeks, 
R I~I~:  Scar sizes (% risk) at 6 weeks were similar among the 6 groups, 
After RP, compared te RP controls over 0 weeks, both EL and AML prOduced 
LV unloading and preserved ejection fraction, regional asynergy and infarct 
segment length but EL mum effectively limited hypertrophy, presented ias- 
tolic (d) and sy~tollc volumes, nftanuatod infarct wall thickness and prosonrod 
regional and global shape, LV unloading was also more sustained with EL, 
Similar benefits and dllforencos with EL and AML wore found with no RP, 
Shams showed no ch,ngos, 
.X% Control (C) Enrdapnl Arnlodlplno 
((~ weeks) RP No RP RP No RP RP No RP 
LV votume (d) . t~( I  ca0 ~. 6t 5t4" 5±5 ".t 7.t6" 11 t6" 
LV rottss 4t-6 lS±0 t t916"  6~5 ",I,'~ 8±6 t 12~ 1" 
"p ~ 0.05 EL or AML vs C: tp .. 005 RP vs, No PiP; tp .  005 EL vs AML 
Con~usfon: The greater effectiveness ot EL over AML in limiting hyper- 
trophy during healing after ropedused MI may be duo to more sustainod 
unloading and, possibly, groator nntltrophic effects of EL. 
• Functional and Electrophyslologlcal 
Consequences of Chronic Treatment With 
Splronolactone In Comparison With Llslnoprll 
During Low.Flow Ischemla and Reperfuslon In 
Isolated Rat Hearts 
A. Rochetaing, A. Furber, L. Marescau, C. Barbo. E Geslin, A. Tadai, 
P. Kreher. Neuroph)~. iotogy and Cardiology department, Universal, Hospital, 
Angers, France 
Background and Methods: The objective of tl~is tudy was to determine the 
effects ot one month chronic treatment with spirenolactono (n = 7), a potas- 
sium-sparing dl~Jretic, in comparison with lisinopril (n = 12), an ACE inhibitor, 
on the recovery of contractility, repedusion-inducod ventncular tachycardias 
and action potential (AP) parameters after 25 minutes low-flow ischemia (0,3 
mVmn) and 30 minutes ot reperfusion. 
Results: With lisinopril significant decreases are observed during is- 
chemia and reperfusion on the left ventricular action potential durations 
(APDgo) (46 ms versus 54 ms). With spironolactone a great increase in 
right ventricular APD~o is observed (51 ms versus 36 ms). Aft-~r a low-flow 
ischemia/repedusion protocole, the recovery of contractility issignificantly in- 
creased in both treated groups but the improvement isbetter in rats treated by 
spirenolactone (70.6% versus 33,6%). The incidence of ventricular tachycar- 
dias is dramatically reduced in spirenolactone group, Moreover, in rats treated 
with spironolactone, the ventricular tachycardias duration during repedusion 
is ShOrter and at the end of reperfusion ventricular tachycardias are com- 
pletely suppressed. 
Control Ll~lnopnl Spimnolactone 
APD0oLV - APD~oRV m~ 18 0 0 
Recovery (%) 3.0 336 706 
% ot VT Incidence 100 50 25 6 
% VT 30 mn 50 58,3 0 
Conclus/on: These data 8gggost a more beneficial effect of chronic 
splronolsctono treatment In comparison with flslnoprB tmalmont in mt with 
myocardial t5chemia with a algnlficant reduction In teperfusion.indt~'e¢l at.
thythmlas and an improvement of contmctilo recoven/, 
~ Concentrat ion Oependeacy Reaponme of to 
Losartan on Post.Is©heroic Mechan!ea! Function 
in Isolated Working Rat Hearts 
W,R, Ford, A,S, Claeachan, B.I, Jugduft, Umversffy ¢)tAtt~erta, Edmonftm, 
AIt~rfa, Cantlclzl 
• !~gmgnd: The concontretlon.msponso lelati0nshlp for angiotensln !1 AT~ 
receptor antagonism on recavew of tell vontncutar (LV) mechamca! fuoct~m 
(LV work) after tschemia mperfosi0n (IR) has not been definecl. We therefore 
evaluated the concentration response (CR) to IOsartan in isolated working 
rat heads subjected to IR 
Methods: Baseline LV work was measured over 50 rain at aemf~c pertu- 
sion prior to 30 rain at global ischemia and 30 min of repertuston, leo=easing 
concentrations of Iosanan (| to 1000 tamer/L) were added 5 rain pnm to 
ischemia and were present throughout IR. 
Reset:In controls (C), LV work recovered to 53% ot aerol~c baseline (1.0 
~t; 0,1 J), The CR to Iosartan was "bell.shaped =with significant depression 
of post.ischemio LV work at concentrations ot 1 and 1000 i,mot4. (O0 ± 0 J 
and 0.12 .t. 0,1 J, respectively). 
% recovery of LV work 
100 I 
1 t~ P <0,05 vs control (C) 
B 
-6 -5 -4 -3 
Log [Ioaartan| pmollL 
Conclusions: The CR for Iosartan ts not that of a "classical" antagonzst. 
This suggests that the effects of Iosartan on post-tschemie recovery m=ght 
be due to multiple interacting receptor and non-receptor mechanisms m th=s 
modot of acute IR, 
I1108-111 I Na+/H* Ion Inhibitor, Cariporide, a Exchange 
Prolongs Survival In Rats With Experimental 
Myocardial Infarction 
M.A. Pteffer, P.V. Finn. J.B. Gannon, J.M. Pfeffer. Brigham and Women's 
Hospital, Harvard Medcal School, Boston, MA, USA 
Background: Sodium-hydrogen ion exchange inhibitor's attenuate intracel- 
lular acidosis and, thereby, calcium influx in ischemia. Preadministration of 
canporide (CAR) in animal models of coronary aden/ligation (CAL) results in 
less ischemic damage, more preserved LV function, and fewer arrhylhmias. 
Methods: To determine its influence on LV function and remodeling, we 
administered CAR (50 mg~g) or vehicle (VEH) by s.c. injection 75 man 
following CAL and 15 min pnor to repedusion (90 rain CAL) and again 6 h 
after infarction, On the subsequent 2 days, s.c. injections of CAR were given 
3 times per day, then in solid food (3000 ppm) for an additional 19 days. 
Results: A hemodynamic study pedormed 3 weeks post-MI did not detect 
a significant difference in LVEDP or LV volume between animals treated 
with VEH or CAR at comparable infarct sizes. However, a trend (P < 0.068) 
for greater survival with CAR prompted additional studies. Of the final 103 
animals with MI that slfrvived 75 man post-ligation to be injected with VEH or 
CAR, there ware fewer deaths in the CAR group (18%, 10/56 vs. 36%, 17/47; 
P < 0.035), despite no difference in MI size (301% vs. 33.8%, P --- NS). 
Conclusion: The survival benefit of cariporide treatment following coronary 
arter~ hgation in the rat is not related to a favorable effect on LV remodeling 
but is consistent with a reduction in fatal arrhythmias (ventricular fibrilla- 
tion), which SUpports the bbserv,~lion that a sodium-hydrogen ion exchange 
inhibitor aises VF threshold during acute myocardial ischemia/necrosis. 
